Epidemiological Characteristics and Spatio-Temporal Distribution of Hepatitis A in Spain in the Context of the 2016/2017 European Outbreak.
MSM
epidemiological surveillance
hepatitis A virus
outbreaks
space-time clustering
urban population
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
14 12 2022
14 12 2022
Historique:
received:
08
11
2022
revised:
02
12
2022
accepted:
09
12
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
27
12
2022
Statut:
epublish
Résumé
The aim of our study was to describe the results of the epidemiological surveillance of hepatitis A infections in Spain in the context of the 2016/2017 European outbreak, particularly of hepatitis A outbreaks reported in the MSM population, incorporating the results of a spatio-temporal analysis of cases. Hepatitis A cases and outbreaks reported in 2016-2017 to the National Epidemiological Surveillance Network were reviewed: outbreaks in which some of the cases belonged to the MSM group were described, and clusters of hepatitis A cases in men and women were analysed using a space-time scan statistic. Twenty-six outbreaks were identified, with a median size of two cases per outbreak, with most of the outbreak-related cases belonging to the 15-44 years-old group. Nearly 85% occurred in a household setting, and in all outbreaks, the mode of transmission was direct person-to-person contact. Regarding space-time analysis, twenty statistically significant clusters were identified in the male population and eight in the female population; clusters in men presented a higher number of observed cases and affected municipalities, as well as a higher percentage of municipalities classified as large urban areas. The elevated number of cases detected in clusters of men indicates that the number of MSM-related outbreaks may be higher than reported, showing that spatio-temporal analysis is a complementary, useful tool which may improve the detection of outbreaks in settings where epidemiological investigation may be more challenging.
Identifiants
pubmed: 36554666
pii: ijerph192416775
doi: 10.3390/ijerph192416775
pmc: PMC9778781
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Euro Surveill. 2015 Apr 16;20(15):
pubmed: 25953129
Euro Surveill. 2017 Feb 23;22(8):
pubmed: 28251892
Rev Esp Salud Publica. 2020 Jan 24;94:
pubmed: 31974339
J Nurs Manag. 2021 Jan;29(1):32-42
pubmed: 33065773
Liver Int. 2018 Apr;38(4):588-593
pubmed: 28980376
Int J Health Geogr. 2013 Mar 16;12:15
pubmed: 23497235
Wkly Epidemiol Rec. 2012 Jul 13;87(28/29):261–76
pubmed: 22905367
Vaccine. 2015 Oct 13;33(42):5723-5727
pubmed: 26190091
Vaccine. 2019 May 9;37(21):2849-2856
pubmed: 30992222
Euro Surveill. 2018 Aug;23(33):
pubmed: 30131095
Int J Health Geogr. 2017 Dec 2;16(1):45
pubmed: 29197383
Int J Health Geogr. 2012 May 29;11:17
pubmed: 22642702
Hum Vaccin Immunother. 2019;15(2):426-432
pubmed: 30431383
Euro Surveill. 2018 Jun;23(23):
pubmed: 29897040
Epidemiol Infect. 2010 Jun;138(6):873-83
pubmed: 19796449
Vaccine X. 2019 Feb 28;1:100014
pubmed: 31384736
BMC Infect Dis. 2012 Jan 20;12:11
pubmed: 22264382
Int J Infect Dis. 2021 Feb;103:146-153
pubmed: 33207272
Acta Biomed. 2020 Apr 10;91(3-S):106-110
pubmed: 32275274
Epidemiol Infect. 2016 May;144(7):1528-37
pubmed: 26566273
J Gen Virol. 2003 Dec;84(Pt 12):3191-3201
pubmed: 14645901
PLoS One. 2017 Nov 10;12(11):e0185428
pubmed: 29125835
Epidemiol Infect. 2013 Nov;141(11):2354-64
pubmed: 23347688
Euro Surveill. 2009 Nov 26;14(47):
pubmed: 19941803